Zymeworks surges on positive Phase 3 Ziihera data in HER2-positive cancer. Discover key catalysts and what’s next for ZYME stock.

ACADIA 2025 brought together leading voices in tech and design to share how algorithms, software and data analysis will ...

Luzerne County is currently working with Kittelson & Associates, a transportation engineering and planning consulting firm, ...

Retail traders focused on AI-driven biopsy findings and clearer dose-response exuded increased confidence in pemvidutide’s ...

Jazz Pharmaceuticals and Zymeworks announced positive topline phase 3 results for Ziihera in HER2-positive GEA. Click here to ...

Why you don’t want to miss this: Besides being the current leader in the metal AM market, EOS has been innovating at a rapid ...

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory ...

IFS and Anthropic have teamed up to introduce Resolve, an AI platform designed to support industrial field workers by ...

The largest-ever Space Pavilion at the Dubai Airshow 2025 kicked off its activities with a tour by His Excellency Dr. Ahmad ...

The critical question facing investors is whether December's clinical data release will provide the catalyst needed to reverse the current negative trend. The coming weeks will determine if analyst ...

Facial age estimation is under increased scrutiny as regulations like the Online Safety Act introduce millions of people to ...

The Global Electronic Data Capture Software Market Size projected to grow at a CAGR of 14.5% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals ...